Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Sacubitril/Valsartan Increases Physical Activity in Systolic Heart Failure

Sacubitril/Valsartan Increases Physical Activity in Systolic Heart Failure

By

Patients with systolic heart failure see physical benefits with sacubitril/valsartan.

FDA Approves Bosentan for Pediatric Pulmonary Arterial Hypertension

FDA Approves Bosentan for Pediatric Pulmonary Arterial Hypertension

By

Bosentan has been approved for use in pediatric pulmonary arterial hypertension in children aged 3 years or older.

FDA Approves Pitavastatin for Mixed Dyslipidemia and Hyperlipidemia

FDA Approves Pitavastatin for Mixed Dyslipidemia and Hyperlipidemia

By

The FDA has approved a new pitavastatin for the treatment of primary hyperlipidemia or mixed dyslipidemia.

FDA Clears Acoustic Device for Heart Murmur Detection

FDA Clears Acoustic Device for Heart Murmur Detection

By

The FDA has granted clearance for a new non-invasive acoustic and electrocardiogram device for the detection of physiological and pathological heart murmurs.

Heart Failure: Fixed-Dose vs Off-Label Combos for Black Patients

Heart Failure: Fixed-Dose vs Off-Label Combos for Black Patients

By

Study finds genuine difference between a fixed-dose combination of isosorbide dinitrate plus hydralazine HCl and an off-label combination of the separate generic drugs for the treatment of heart failure in African American patients.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-Newsletters